Intra-Cellular Therapies Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Hello, Good morning, everyone. My name is Jess Fye. I'm a senior biotech analyst at JPMorgan.
Welcome to the 48th Annual Healthcare Conference. I'm really pleased to be kicking off the conference this morning with Intra-Cellular. I'm joined by the company's Chairman and Chief Executive Officer, Dr. Sharon Mates. I'm going to turn it over to her for a presentation, and then we're going to go into Q&A after that. (Operator Instructions)
So with that out of the way, Sharon, let me turn it over to you.
Great. Thanks so much, Jess. And here we are again, virtually. I wish you and everyone a happy New Year. And with that, I will start our presentation. Before I do, to tell you, I'm joined here today by Mark Neumann, our Chief Commercial Officer; Larry Hineline, our Chief Financial Officer; and Suresh Durgam, our Chief Medical Officer.
Our presentation today will contain
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |